Skip to content
OpenCapital
Get started

Oric Pharmaceuticals, Inc. ORIC EBITDA

EBITDA at other companies

ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
-$46.67M+30.9%
CG Oncology logo
CG OncologyCGON
-$65.55M-55.4%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
-$57.87M-66.5%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-$30.39M+28.0%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$52.98M-147%
Pfizer logo
PfizerPFE
——

Other financials

Income statement

See full
Operating income-$39.6M-21.1%
Net income-$35.8M-19.1%
EPS (diluted)-$0.34+19.0%

Balance sheet

See full
Cash & equivalents$56.4M+14.3%
Total debt$3.3M+2.6%
Total equity$415.6M+89.1%
Total assets$436.8M+79.8%

Cash flow

See full
Operating cash flow-$32.4M+0.3%
CapEx$2.0K-99.5%
Free cash flow-$32.4M+1.5%

Valuation

See full
Market cap$976.17M+23.0%
Enterprise value$923.07M+23.5%

Returns & leverage

See full
Return on equity-42.6%-4.6pp
Debt / equity0×0.0×
Current ratio16.3×+4.3×

Where this comes from

Calculated from Oric Pharmaceuticals, Inc.’s reported figures.

−$39.6Mebit+
$270.0KDepreciation Depletion & Amortization
=-$39.35M

The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oric Pharmaceuticals, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oric Pharmaceuticals, Inc.'s EBITDA?
Oric Pharmaceuticals, Inc. (ORIC) reported EBITDA of -$39.35M in Q1 2026.
How has Oric Pharmaceuticals, Inc.'s EBITDA changed year-over-year?
Oric Pharmaceuticals, Inc.'s EBITDA decreased by 21.4% year-over-year, from -$32.42M to -$39.35M.
What is the long-term trend for Oric Pharmaceuticals, Inc.'s EBITDA?
Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s EBITDA has grown at a 16.1% compound annual growth rate (CAGR), from -$77.97M to -$141.78M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.